Global surgical navigation system market is forecasted to attain revenues of $1046.8 million value by 2023. The growth in the market will be led by the rising prevalence of orthopedic, neurological, and ENT disorders, increasing adoption of minimally invasive surgical procedures, rising aging population, technological advancements, and increasing regulatory approval for navigation systems, that can be used in various surgeries.
Asia-Pacific surgical navigation system market is expected to witness fastest growth, mainly due to aging population, rising incidence of burns cases, increasing diabetic patients, and per capita income. Elderly people have a slow healing of wounds as they have reduced regenerative capabilities and weak immune system, which leads to different ailments, thereby boosting the market for surgical navigation systems in the region. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the number of people aged 65 years and above, constituted approximately 11.4% of population in 2013, and the count is estimated to reach approximately 20% of the population by 2050.
Globally, the key providers in the surgical navigation system industry are collaborating to gain a larger market share. For instance, in June 2017, Elekta AB, a company providing radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders and Brainlab AG, entered into an agreement, according to which, Brainlab AG was made the authorized distributor of Elekta’s stereotactic solutions for neurosurgery in select markets in the Europe namely; France, Belgium, Poland, Liechtenstein, Luxemburg, Portugal and Spain.
Some of the other key players operating in the surgical navigation system market include Koninklijke Philips N.V., Fiagon GmbH, Orthalign, Inc., Stryker Corporation, Scopis GmbH, Medtronic plc, Siemens AG, General Electric Company, B. Braun Melsungen AG and Zimmer Biomet Holdings, Inc.
Know More: http://bit.ly/2IG55wk
留言列表
